MIRA INFORM REPORT

 

 

Report No. :

352293

Report Date :

03.12.2015

 

IDENTIFICATION DETAILS

 

Name :

DEXPEN S.A.

 

 

Registered Office :

25 De Mayo 444, Montevideo, Montevideo 11000

 

 

Country :

Uruguay

 

 

Year of Establishment :

1985

 

 

Legal Form :

Sociedad Anónima

 

 

Line of Business :

The company is dedicated to the wholesale of pharmaceutical raw materials.

 

 

No. of Employee :

4

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Small Company

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Uruguay

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

STATUTORY INFORMATION

 

Legal Name:

DEXPEN S.A.

Trade Name:

Dexpen

RUC:

2.11922E+11

Date Created:

1985

Date Incorporated:

24/04/2013

Legal Address:

25 De Mayo 444

Montevideo, Montevideo 11000

Uruguay

Operative Address:

25 De Mayo 444

Montevideo, Montevideo 11000

Uruguay

Telephone:

598 02 9160667

Fax:

598 02 9152044

Legal Form:

SOCIEDAD ANÓNIMA

Email:

NA

Registered in:

Uurguay

Website:

www.lecueder.com.uy

Contact:

Manon Lecueder De San Vicente (Agent)

Staff:

4

Activity:

Pharmaceutical Wholesale Industry

 

 

BANKS

 

Banco Central de Uruguay

 

 

 The company does not make its banking data public

 

 

History

 

 The company was established in 1980

 

 

 

 

PRINCIPAL ACTIVITY

 The company is dedicated to the wholesale of pharmaceutical raw materials.

 

It does not operate within Uruguay with its offices; it just uses its legal address to carry operations there.

It uses its agent’ address which is an accounting firm: Estudio Carlos José Lecueder & Asociados

 

Products/Services description:

Heparin Chondroitin Sulfate, PMSG, Pancreatin, Pepsine, Chymotrypsine, Filgrastim and secondary other products Foodand Wines

Brands:

NA

Sales are:

Wholesale

Clients:

Distributors

Suppliers:

NA

Operations area:

National and International

The company imports from

Argentina

The company exports to

Latin America

The subject employs

4 employees

Payments:

No Complaints

 

 

 

 

LOCATION

Headquarters :

25 De Mayo 444

Montevideo, Montevideo 11000

Uruguay

Branches:

The company does not have branches

 

 

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

Listed at the stock exchange:

NO

Capital:

NA

Shareholders:

The company would be related to:

 

Dexpen SA

Maipu 671 8th Floor, Buenos Aires,

Argentina

 

This company would be owned by:

 

Julio Ortega

Management:

Manon Lecueder De San Vicente, President

Juan Pedro Malinow Lecueder, Director

Patricia Panzl Tasende, Secretary

 

Estudio Carlos José Lecueder & Asociados 

25 De Mayo 444

Montevideo, Montevideo 11000

Uruguay

 

 

FINANCIAL INFORMATION

 This is a private company which does not make its financials

public.

 

 

 There are no negative for the subject.

 

 

 

LEGAL FILINGS

 

 

 There are no legal connected to the subject

 

 

SUMMARY

 

 Dexpen is an Uruguayan company dedicated to the Wholesale of pharmaceutical products.

 

The company has a small sized structure and distribuís for South America.

 

It is managed by an accounting firm located in Uruguay, however; it would not have ts main offices there.

 

There are no negative records. 

 

 

RISK INFORMATION

 

 

 

DEBTS

Controlled

PAYMENTS

No Complaints

CASH FLOW

Normal

STATUS

Active

 

 

INTERVIEW

 

NAME

NA 

POSITION

Agent 

COMMENTS

They refused to provide any data on the subject. 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.66.62

UK Pound

1

Rs.100.34

Euro

1

Rs.70.67

UYU

1

Rs. 2.25

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

ASH

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.